Lennon David James bought WHWK
March 1, 2026 · Form 4 insider transaction
Lennon David James bought 16,250 shares of Whitehawk Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 9 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,250
Price
N/A
Total value
N/A
InsiderLennon David James
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 1, 2026
Filing dateMarch 10, 2026
Shares owned after49,679
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.